111 (YI) EBIT Growth (1y) (2018 - 2025)
111 (YI) EBIT Growth (1y) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 102.57 Bn | 97.41 Bn | 3.69 Bn | 27.32% |
| 2 | Cencora | 61.35 Bn | 58.53 Bn | 3.61 Bn | 29.11% |
| 3 | Cardinal Health | 54.15 Bn | 49.30 Bn | 2.56 Bn | 70.33% |
| 4 | Henry Schein | 10.05 Bn | 9.89 Bn | 1.10 Bn | 13.25% |
| 5 | Akso Health | 671.90 Mn | 671.70 Mn | - | - |
| 6 | Edap Tms | 154.62 Mn | 133.07 Mn | 7.34 Mn | -23.01% |
| 7 | Accendra Health | 90.69 Mn | 83.04 Mn | 263.41 Mn | 11.48% |
| 8 | 111 | 31.31 Mn | -27.44 Mn | 18.18 Mn | -13,826.22% |
| 9 | Cosmos Health | 13.28 Mn | 10.84 Mn | 1.51 Mn | -10.60% |
| 10 | VitaNova Life Sciences | 11.51 Mn | 9.91 Mn | 264,662.00 | -110.15% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 95.41% |
| Sep 30, 2025 | -195.25% |
| Jun 30, 2025 | -97.14% |
| Mar 31, 2025 | -96.13% |
| Dec 31, 2024 | 96.55% |
| Sep 30, 2024 | 103.06% |
| Jun 30, 2024 | 108.06% |
| Mar 31, 2024 | 116.31% |
| Dec 31, 2023 | -85.06% |
| Sep 30, 2023 | 2.81% |
| Jun 30, 2023 | 52.05% |
| Mar 31, 2023 | 80.36% |
| Dec 31, 2022 | 4.01% |
| Sep 30, 2022 | 58.33% |
| Jun 30, 2022 | 59.25% |
| Mar 31, 2022 | 39.07% |
| Dec 31, 2021 | 26.18% |
| Sep 30, 2021 | -51.24% |
| Jun 30, 2021 | -122.69% |
| Mar 31, 2021 | -64.68% |